Carlo Cervellati

Via Luigi Borsari 46
Ferrara, 44121, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 132 publications

Reduced Serum PON1 Lactonase Activity Is Associated with Mild Cognitive Impairment and Mixed Dementia.

Reduced Serum PON1 Lactonase Activity Is Associated with Mild Cognitive Impairment and Mixed Dementia.

Journal: Antioxidants (Basel, Switzerland)

Published: July 03, 2026

Why acetylcholinesterase inhibitors should be considered disease-modifying drugs for Alzheimer's disease?

Why acetylcholinesterase inhibitors should be considered disease-modifying drugs for Alzheimer's disease?

Journal: Aging clinical and experimental research

Published: February 04, 2026

Palmitic acid differently modulates extracellular vesicles and cellular fatty acid composition of SGBS adipocytes without impairing their insulin signaling.

Palmitic acid differently modulates extracellular vesicles and cellular fatty acid composition of SGBS adipocytes without impairing their insulin signaling.

Journal: Frontiers in endocrinology

Published: September 05, 2025

Late-onset alzheimer's disease, atherosclerosis, and cerebrovascular disease. A complex relationship too often neglected: a narrative review.

Late-onset alzheimer's disease, atherosclerosis, and cerebrovascular disease. A complex relationship too often neglected: a narrative review.

Journal: Aging clinical and experimental research

Published: August 28, 2025

Effect of Dietary PUFAs and Antioxidants on Antioxidant and Anti-Inflammatory Functions of HDL in a Cohort of Women.

Effect of Dietary PUFAs and Antioxidants on Antioxidant and Anti-Inflammatory Functions of HDL in a Cohort of Women.

Journal: Antioxidants (Basel, Switzerland)

Published: August 22, 2025

Long-Term Effect of Acetylcholinesterase Inhibitors on Behavioral and Psychological Symptoms of Dementia.

Long-Term Effect of Acetylcholinesterase Inhibitors on Behavioral and Psychological Symptoms of Dementia.

Journal: International journal of geriatric psychiatry

Published: July 10, 2025

Mechanisms, Mediators, and Pharmacological Approaches Targeting Brain Cholesterol Transport in Alzheimer's Disease.

Mechanisms, Mediators, and Pharmacological Approaches Targeting Brain Cholesterol Transport in Alzheimer's Disease.

Journal: Current pharmaceutical design

Published: April 29, 2025

Sex-difference in the association between Triglyceride-Glucose (TyG) index and dementia.

Sex-difference in the association between Triglyceride-Glucose (TyG) index and dementia.

Journal: Journal of diabetes and metabolic disorders

Published: April 25, 2025

Impact of Antioxidant and Anti-Inflammatory Functions of HDL in Diseases-2nd Edition.

Impact of Antioxidant and Anti-Inflammatory Functions of HDL in Diseases-2nd Edition.

Journal: Antioxidants (Basel, Switzerland)

Published: March 13, 2025

PON1 and PON3 in Alzheimer's Disease: Similar Functions but Different Roles.

PON1 and PON3 in Alzheimer's Disease: Similar Functions but Different Roles.

Journal: Antioxidants (Basel, Switzerland)

Published: September 10, 2024

BACE-1 and ADAM-10 as Potential Peripheral Biomarkers for Alzheimer's Disease.

BACE-1 and ADAM-10 as Potential Peripheral Biomarkers for Alzheimer's Disease.

Journal: Current pharmaceutical design

Published: July 17, 2024

Serum Beta-Secretase 1 Activity Is a Potential Marker for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Dementia: A Pilot Study.

Serum Beta-Secretase 1 Activity Is a Potential Marker for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Dementia: A Pilot Study.

Journal: International journal of molecular sciences

Published: July 05, 2024

Showing 1-12 of 132

Last Updated: 09/26/2026